UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
UNITED THERAPEUTICS Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$543.15+10.03 (+1.88%)
Close on Oct 19, 2026
- Market cap
- $24.88B
- P/E (TTM)
- 19.4
- Dividend yield
- –
SEC filings
40 of United Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 21, 2026 | Oct 22, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 13, 2026 | Oct 14, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2026 | Jul 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 26, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 9, 2026 | Mar 9, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 2, 2026 | Mar 2, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2026 | Feb 25, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2026 | Jan 22, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2025 | Oct 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 29, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 2, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2025 | Aug 1, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2025 | Jun 27, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2025 | Apr 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | Apr 30, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 26, 2025 | Apr 29, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 25, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 26, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2024 | Oct 30, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Oct 30, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2024 | Jul 31, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Jul 31, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2024 | Jun 27, 2024 | SEC EDGAR |
| Current report | 8-K | May 1, 2024 | May 1, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 1, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 26, 2024 | Apr 29, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 29, 2024 | Mar 29, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2024 | Mar 25, 2024 | SEC EDGAR |